EUVIMEDEUVIMED entdecken
Crossref

290 Clinical Study of RLS-1496 Topical Cream: Targeting Cellular Senescence in Patients with Mild to Moderate Plaque Psoriasis, Atopic Dermatitis, and Aged Skin

Mary Spellman, Frederick Beddingfield, Marco Quarta, Ofir Moreno

Journal of Investigative Dermatology · 2025-11 · 145 (11) · e77

DOI: 10.1016/j.jid.2025.09.294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2025-11. Verfasst von Mary Spellman und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Spellman, M., Beddingfield, F., Quarta, M., & Moreno, O. (2025). 290 Clinical Study of RLS-1496 Topical Cream: Targeting Cellular Senescence in Patients with Mild to Moderate Plaque Psoriasis, Atopic Dermatitis, and Aged Skin. Journal of Investigative Dermatology, 145(11), e77. https://doi.org/10.1016/j.jid.2025.09.294

Vancouver

Spellman M, Beddingfield F, Quarta M, Moreno O. 290 Clinical Study of RLS-1496 Topical Cream: Targeting Cellular Senescence in Patients with Mild to Moderate Plaque Psoriasis, Atopic Dermatitis, and Aged Skin. Journal of Investigative Dermatology. 2025;145(11):e77. doi:10.1016/j.jid.2025.09.294

BibTeX
@article{Spellman2025,
  author = {Spellman, Mary and Beddingfield, Frederick and Quarta, Marco and Moreno, Ofir},
  title = {290 Clinical Study of RLS-1496 Topical Cream: Targeting Cellular Senescence in Patients with Mild to Moderate Plaque Psoriasis, Atopic Dermatitis, and Aged Skin},
  journal = {Journal of Investigative Dermatology},
  year = {2025},
  volume = {145},
  number = {11},
  pages = {e77},
  doi = {10.1016/j.jid.2025.09.294}
}
Kostenlos starten →